Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: dunkin  dogs  pets  childrens  hospital  for  joy  healthcare  health  help  multivu  8444851  nucletron  elekta  esteya  electronic  brachytherapy  skin  cancer  radiation  therapy  treatment  multivu  62823  novartis  ctl019  clinical  data  pediatric  children  young  adults  leukemia  refractory  acute  lymphoblastic  multivu  7393851  adenocarcinoma  appendix  cancer  patients  health  immunotherapy  dendritic  cell  vaccine  multivu  64654  aspiresr  vns  therapy  fda  approval  epilepsy  drug  resistant  health  seizures  medication  doctor  multivu  7651751  clear  men  scalp  therapy  espy  awards  football  tony  gonzalez  shampoo  hair  multivu  62546  jadenu  novartis  iron  chelator  chelation  therapy  blood  transfusions  treatment  medicine  medication  multivu  7440151  leukemia  lymphoma  society  health  medical  therapy  research  cancer  treatments  disease  multivu  7554852  acromegaly  treatment  chiasma  octreotide  capsules  injection  medication  medicine  growth  hormone  multivu  7436451  emoji  app  model  special  needs  children  disabilities  healthcare  health  caregivers  multivu  7823251  livanova  medical  technology  therapy  health  treatment  drug  vns  epilepsy  multivu  7966451  elekta  versa  high  definition  radiation  therapy  cancer  treatments  agility  mlc  oncology  health  technology  multivu  60246 
Search // therapy
Results 97-108 of 109 for ' therapy ' (0 seconds)
Sally Hansen continues to lead in innovation by introducing its new Color Therapy products: a nail polish, top coat, and nail & cuticle oil, inspired by women’s desire to wear beautiful color while simultaneously caring for their nails. Sally Hansen’s Color Therapy nail polish contains a patented micro-delivery system that delivers an argan oil-enriched formula, resulting in intensive nourishment and instant moisture for healthier-looking nails. The Color Therapy nail polish needs no base coat so the oil complex can directly contact the bare nail. 9 out of 10 women experienced a noticeable improvement in their natural nails after wearing the Color Therapy nail polish. Vibrant tones, available in three magnificent palettes, glide on for a radiant, shiny finish with up to 10 days of fade-proof, chip-resistant wear. The Color Therapy nail polish provides the ultimate color that cares while you wear, with everything needed to restore nails without sacrificing luminous color. Complete your manicure with the Color Therapy top coat and nail & cuticle oil, both formulated with the same argan oil contained in the nail polish. The top coat provides an ultra-glossy finish for extended wear, and the nail & cuticle oil, the ultimate in nail therapy, instantly makes nails and cuticles look healthier, restored, and rejuvenated. To view the multimedia release go to: http://www.multivu.com/players/English/7957151-sally-hansen-color-therapy-nail-polish/
Categories // Miscellaneous 
Added: 2980 days ago by MultiVuVideos
Runtime: 0m42s | Views: 772 | Comments: 1
    
 

 

 

Northwestern Medicine’s Bluhm Cardiovascular Institute is celebrating the success of its transcatheter valve program, a pioneering technology that replaces or repairs leaky heart valves without open-heart surgery. On August 25, 2016, more than 50 former transcatheter valve replacement patients and their family members celebrated the life-saving procedure that has extended both their lives and their ability to enjoy them. The Bluhm Cardiovascular Institute hit the milestone of being the first hospital in Illinois to perform the 500th TAVR, or transcatheter aortic valve replacement, since the program’s inception in 2008. Charles J. Davidson, MD, performed the 500th procedure on July 23, 2016. To view the multimedia release go to: http://www.multivu.com/players/English/7049452-northwestern-medicine-transcatheter-valve/
Categories // Miscellaneous 
Added: 3040 days ago by MultiVuVideos
Runtime: 3m32s | Views: 779 | Comments: 0
Not yet rated
 

 

 

Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols. When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.” To view the multimedia release go to: https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
Categories // Miscellaneous 
Added: 2527 days ago by MultiVuVideos
Runtime: 3m51s | Views: 765 | Comments: 3
Not yet rated
 

 

 

Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use. To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
Categories // Science and Technology 
Added: 3891 days ago by MultiVuVideos
Runtime: 2m13s | Views: 769 | Comments: 1
Not yet rated
 

 

 

EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Added: 3632 days ago by MultiVuVideos
Runtime: 0m24s | Views: 761 | Comments: 2
Not yet rated
 

 

 

Oro Valley Audiology 2542 E Vistoso Commerce Loop Rd, Tucson, AZ 85755, USA (520) 825-4770 http://hearintucson.com https://www.google.com/maps?cid=7471816986561274177 https://www.google.com/search?q=Oro+Valley+Audiology&kponly&kgmid=/g/1thx4hd3 As the name suggests, and audiologist is a health-care professional who concentrates on the medical diagnoses, recognition, tracking and treatment of conditions of the auditory and vestibular parts of the ear. These specialists dispense hearing aids, manage and fix up hearing problems and evaluate candidacy for cochlear implants. An audiologist helps style and carry out individual and industrial hearing safety programs, newborn hearing screening programs, and school hearing screening programs. Audiologists have training in anatomy and physiology, hearing aids, cochlear implants, electrophysiology, acoustics, psychophysics, neurology, vestibular function and evaluation, balance disorders, therapy and indication language. Unfortunately, hearing loss is prevalent throughout the U.S.
Tags // audiologist 
Categories // Miscellaneous 
Added: 1675 days ago by johngeltkn
Runtime: 1m9s | Views: 761 | Comments: 0
Not yet rated
 

 

 

Forget all your worries and refresh your mood with relaxing music and get peaceful sleep with sleep music here. Try our soothing music and experience its magic.http://www.easysleepmusic.com
Tags // music  therapy 
Categories // Music 
Added: 4352 days ago by noah52336
Runtime: 8m46s | Views: 724 | Comments: 0
Not yet rated
 

 

 

University of St. Augustine for Health Sciences (USAHS), a leading graduate institution that emphasizes health and rehabilitative sciences education through innovative classroom education, is pleased to announce the installation of SafeGait 360° Balance and Mobility Trainer® on its Austin, Texas campus. The device, which was designed in collaboration with experts in physical therapy (PT) and occupational therapy (OT), works to mitigate the risk of injury from falls, protecting both the patient and therapist. In addition, SafeGait 360°’s dynamic fall protection (DFP) distinguishes between a patient’s intentional downward movement and when a patient is actually falling, which allows therapists to easily modify fall protection sensitivity to accommodate and challenge patients at varying stages of independence. USAHS is one of the first higher education institutions in the nation to install this innovative body-weight support and fall protection system. In addition to conducting ground breaking research with patients and students, faculty members with extensive experience in body-weight treatments aim to open a clinic which will provide new treatment options to patients in the Austin community, and will begin seeing patients in October of this year. To view the multimedia release go to: http://www.multivu.com/players/English/7743851-usahs-safegait-360-physical-therapy/
Categories // Miscellaneous 
Added: 3009 days ago by MultiVuVideos
Runtime: 1m2s | Views: 721 | Comments: 0
Not yet rated
 

 

 

Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital. “This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.” To view the multimedia release go to: https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
Categories // Miscellaneous 
Added: 2762 days ago by MultiVuVideos
Runtime: 1m19s | Views: 683 | Comments: 0
Not yet rated
 

 

 

Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE. To view the multimedia release go to: https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Categories // Miscellaneous 
Added: 2834 days ago by MultiVuVideos
Runtime: 2m41s | Views: 681 | Comments: 0
Not yet rated
 

 

 

A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma. The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor. To view the multimedia release go to: https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
Categories // Miscellaneous 
Added: 2743 days ago by MultiVuVideos
Runtime: 4m28s | Views: 678 | Comments: 1
Not yet rated
 

 

 

Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine. The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection. To view the multimedia release go to: http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
Categories // Miscellaneous 
Added: 3170 days ago by MultiVuVideos
Runtime: 1m41s | Views: 651 | Comments: 0
Not yet rated
 

 

 

Page 9 of 10  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.